Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 3, 2016
Previous Article Next Article

In silico-driven multicomponent synthesis of 4,5- and 1,5-disubstituted imidazoles as indoleamine 2,3-dioxygenase inhibitors

Author affiliations

Abstract

Indoleamine 2,3-dioxygenase is involved in pathological immune escape and has recently become an attractive target for anti-cancer therapy. 4-Phenylimidazole (4-PI) provides a promising starting point for the development of IDO1 inhibitors. With the aim of discovering more potent ligands, a virtual library of imidazoles synthesizable via the van Leusen multicomponent reaction was created and filtered to afford a set of 4,5- and 1,5-disubstituted imidazoles as virtual lead candidates. The compounds were selected according to their docking score and to their synthetic feasibility, synthesized and biologically evaluated. This experimental approach yielded IDO1 inhibitors with an enhanced potency compared to 4-PI; the most active compounds displayed a low micromolar potency, both in enzymatic and cellular assays, while showing no detectable cellular toxicity. A 3D quantitative structure–activity relationship based on the electrostatic and steric ligand–protein interactions was observed.

Graphical abstract: In silico-driven multicomponent synthesis of 4,5- and 1,5-disubstituted imidazoles as indoleamine 2,3-dioxygenase inhibitors

Back to tab navigation

Supplementary files

Article information


Submitted
31 Jul 2015
Accepted
02 Oct 2015
First published
08 Oct 2015

Med. Chem. Commun., 2016,7, 409-419
Article type
Research Article

In silico-driven multicomponent synthesis of 4,5- and 1,5-disubstituted imidazoles as indoleamine 2,3-dioxygenase inhibitors

S. Fallarini, A. Massarotti, A. Gesù, S. Giovarruscio, G. Coda Zabetta, R. Bergo, B. Giannelli, A. Brunco, G. Lombardi, G. Sorba and T. Pirali, Med. Chem. Commun., 2016, 7, 409
DOI: 10.1039/C5MD00317B

Search articles by author

Spotlight

Advertisements